Search results for "gene signature"

showing 10 items of 13 documents

A Spatially Resolved Dark- Versus Light-Zone Microenvironment Signature Subdivides Germinal Center-Related Aggressive B-Cell Lymphomas

2020

Summary: We applied digital spatial profiling for 87 immune and stromal genes to lymph node germinal center (GC) dark- and light-zone (DZ/LZ) regions of interest to obtain a differential signature of these two distinct microenvironments. The spatially resolved 53-genes signature, comprising key genes of the DZ mutational machinery and LZ immune and mesenchymal milieu, was applied to the transcriptomes of 543 GC-related diffuse large B cell lymphomas and double-hit (DH) lymphomas. According to the DZ/LZ signature, the GC-related lymphomas were sub-classified into two clusters. The subgroups differed in the distribution of DH cases and survival, with most DH displaying a distinct DZ-like prof…

0301 basic medicineStromal cellCancer Cancer Systems Biology02 engineering and technologycancer systems biologyBiologyTranscriptome03 medical and health sciencestranscriptomicsImmune systemmedicinecancerTranscriptomicslcsh:ScienceGeneLymph nodeB cellCancerMultidisciplinaryMesenchymal stem cellGerminal centerGene signature021001 nanoscience & nanotechnologyMolecular biologycancer; cancer systems biology; transcriptomics030104 developmental biologymedicine.anatomical_structurelcsh:Q0210 nano-technologySignature (topology)Cancer Systems BiologySSRN Electronic Journal
researchProduct

Cadmium-Associated Molecular Signatures in Cancer Cell Models

2021

Simple Summary The exposure of cancer cells to cadmium compounds may be associated with the acceleration of tumor progression. It is known that cadmium is a transcriptional regulator, and the study of differentially expressed genes has enabled the identification and classification of cadmium-associated molecular signatures as useful biomarkers that are potentially transferable to clinical research. This review recapitulates the studies that report the detection of such signatures in breast, gastric, colon, liver, lung, and nasopharyngeal tumor cell models, as specifically demonstrated by individual gene or whole genome expression profiling. Abstract The exposure of cancer cells to cadmium a…

0301 basic medicineCancer Researchcadmiumnasopharyngeal cancerReviewBiologygene signaturedifferential expressionliver cancer03 medical and health sciences0302 clinical medicinebreast cancerGene silencingSettore BIO/06 - Anatomia Comparata E CitologiaRC254-282Regulation of gene expressiongastric cancerNeoplasms. Tumors. Oncology. Including cancer and carcinogensGene signaturein vitro cell modelsPhenotypein vitro cell modelGene expression profilinglung cancer030104 developmental biologyOncologycolon cancerTumor progression030220 oncology & carcinogenesisCancer cellCancer researchReprogrammingCancers
researchProduct

Prognostic Significance of Interferon-γ and Its Signaling Pathway in Early Breast Cancer Depends on the Molecular Subtypes

2020

Interferons are crucial for adaptive immunity and play an important role in the immune landscape of breast cancer. Using microarray-based gene expression analysis, we examined the subtype-specific prognostic significance of interferon-&gamma

OncologyMicroarrayReceptor ErbB-2animal diseasesKaplan-Meier Estimatelcsh:ChemistryMedicinelcsh:QH301-705.5Spectroscopymolecular subtypesHazard ratioGeneral MedicineinterferonMiddle AgedAcquired immune systemProgression-Free SurvivalComputer Science ApplicationsGene Expression Regulation NeoplasticReceptors EstrogenCohortFemaleReceptors ProgesteroneSignal Transductionmedicine.medical_specialtyBreast Neoplasmschemical and pharmacologic phenomenaDisease-Free SurvivalArticleCatalysisInorganic ChemistryInterferon-gammaBreast cancerImmune systembreast cancerInternal medicineBiomarkers TumorHumansPhysical and Theoretical ChemistryMolecular BiologyAgedNeoplasm Stagingbusiness.industryProportional hazards modelOrganic Chemistrybreast cancer ; prognosis ; interferon ; molecular subtypesbiochemical phenomena metabolism and nutritionGene signaturemedicine.diseaselcsh:Biology (General)lcsh:QD1-999bacteriaprognosisbusinessInternational Journal of Molecular Sciences
researchProduct

Gene signatures in CRC and liver metastasis

2011

Colorectal cancer (CRC) is one of the most common causes of cancer-related death with a worldwide incidence of almost a million cases annually in both males and females. The accelerated decrease in CRC incidence rates from 1998 to 2006 largely reflects the advances in diagnosis and treatment that have enabled to detect and remove precancerous polyps. However, the screening technology has not resulted in major improvements in the prognosis of patients with advanced cancer and the liver metastasis remains the major cause of death in CRC. About 25% of patients have detectable liver metastasis at diagnosis, that are classified as “synchronous” lesions and approximately 70% of patients develop a…

Oncologymedicine.medical_specialtyColorectal cancerbusiness.industrySettore MED/06 - Oncologia MedicaIncidence (epidemiology)Medicine (all)DiseaseGene signaturemedicine.diseasePrecancerous Polypdigestive system diseasesMetastasisInternal medicinemedicineCancer researchbusinessGeneCause of death
researchProduct

Parathyroid hormone-related protein (PTHrP)-dependent modulation of gene expression signatures in cancer cells

2022

PTHrP is encoded by PTHLH gene which can generate by alternative promoter usage and splicing mechanisms at least three mature peptides of 139, 141 and 173 amino acids with distinct carboxy terminus. PTHrP may undergo proteolytic processing into smaller bioactive forms, comprising an amino terminus peptide, which is the mediator of the "classical" PTH-like effect, as well as midregion and carboxy terminus peptides that act as multifaceted critical regulator of proliferation, differentiation and apoptosis via the reprogramming of gene expression in normal and neoplastic cells. Moreover, a nuclear/nucleolar localization signal sequence is present in the [87-107] domain allowing PTHrP nuclear i…

Parathyroid HormoneNeoplasmsParathyroid Hormone-Related ProteinHumansApoptosisSettore BIO/06 - Anatomia Comparata E CitologiaPeptidesTranscriptomeGene signatures Bone tumor Breast tumor Gastrointestinal tumor Prostate tumor Lung cancer Leukemia/lymphoma
researchProduct

Transcriptional changes through menstrual cycle reveal a global transcriptional derepression underlying the molecular mechanism involved in the windo…

2021

The human endometrium is a dynamic tissue that only is receptive to host the embryo during a brief time in the middle secretory phase, called the window of implantation (WOI). Despite its importance, regulation of the menstrual cycle remains incompletely understood. The aim of this study was to characterize the gene cooperation and regulation of menstrual cycle progression, to dissect the molecular complexity underlying acquisition of endometrial receptivity for a successful pregnancy, and to provide the scientific community with detailed gene co-expression information throughout the menstrual cycle on a user-friendly web-tool database. A retrospective gene co-expression analysis was perfor…

Embryologysystems biology of the menstrual cycleTranscription Geneticendometrial receptivitymedia_common.quotation_subjectweighted gene correlation network analysis (WGCNA)BiologyCohort StudiesEndometriumgenetic regulation of menstrual cyclePregnancymicroRNAGeneticsHumansEmbryo ImplantationMolecular BiologyGeneTranscription factorgene co-expressionDerepressionMenstrual cycleMenstrual Cycletranscription factormedia_commonrecurrent implantation failuremicroRNAObstetrics and GynecologyGene Expression Regulation DevelopmentalEmbryoCell BiologyGene signatureCell biologyendometrial transcriptomicsnuclear hormone receptorReproductive MedicineNuclear receptorEmbryo LossFemaleTranscriptomeDevelopmental Biology
researchProduct

Individual patient risk stratification of high-risk neuroblastomas using a two-gene score suited for clinical use

2015

Several gene expression-based prognostic signatures have been described in neuroblastoma, but none have successfully been applied in the clinic. Here we have developed a clinically applicable prognostic gene signature, both with regards to number of genes and analysis platform. Importantly, it does not require comparison between patients and is applicable amongst high-risk patients. The signature is based on a two-gene score (R-score) with prognostic power in high-stage tumours (stage 4 and/or MYCN-amplified diagnosed after 18 months of age). QPCR-based and array-based analyses of matched cDNAs confirmed cross platform (array-qPCR) transferability. We also defined a fixed cut-off value iden…

OncologyCancer Researchmedicine.medical_specialtyTreatment regimenbusiness.industryPatient riskTransferabilityCancerGene signaturemedicine.diseaseBioinformaticsOncologyNeuroblastomaInternal medicinemedicineStage (cooking)businessGeneInternational Journal of Cancer
researchProduct

From High-Throughput Microarray-Based Screening to Clinical Application: The Development of a Second Generation Multigene Test for Breast Cancer Prog…

2013

Several multigene tests have been developed for breast cancer patients to predict the individual risk of recurrence. Most of the first generation tests rely on proliferation-associated genes and are commonly carried out in central reference laboratories. Here, we describe the development of a second generation multigene assay, the EndoPredict test, a prognostic multigene expression test for estrogen receptor (ER) positive, human epidermal growth factor receptor (HER2) negative (ER+/HER2−) breast cancer patients. The EndoPredict gene signature was initially established in a large high-throughput microarray-based screening study. The key steps for biomarker identification are discussed in det…

Microarrayendocrine therapyBiomedical EngineeringBioengineeringReviewComputational biologyBiologyGene signaturemedicine.diseaseBioinformaticsIndividual riskBiochemistryFirst generationlcsh:BiochemistryMultigene expressionbreast cancerBreast cancerReal-time polymerase chain reactionmedicineProficiency testinglcsh:QD415-436multigene testEndoPredictBiotechnologyMicroarrays
researchProduct

1432P Characterizing diversity in the immune profile by a transcriptomic customized gene signature to potentially personalize treatment in advanced g…

2021

TranscriptomeImmune systemOncologybusiness.industrymedia_common.quotation_subjectMedicineHematologyComputational biologyAdvanced gastric cancerGene signaturebusinessDiversity (politics)media_commonAnnals of Oncology
researchProduct

Is endometrial receptivity transcriptomics affected in women with endometriosis? A pilot study

2015

Endometrial receptivity is still questioned today in women with endometriosis. The aim of this study was to assess the endometrial receptivity gene signature in patients with different stages of endometriosis by investigating transcriptomic modifications of their endometrium using the endometrial receptivity array (ERA) test. A prospective, interventional multicentre pilot trial was designed and implemented in two university-affiliated infertility units from Belgium and Spain. Gene expression microarray was used to diagnose the receptivity status by quantifying the expression of 238 specific genes directly related to human endometrial receptivity. Unsupervised hierarchical clustering showed…

AdultInfertilitymedicine.medical_specialtyEndometriosisReceptivityEndometriosisPilot ProjectsBiologyEndometriumEndometriumBiopsymedicineHumansProspective StudiesProspective cohort studyGynecologymedicine.diagnostic_testGene Expression ProfilingObstetrics and GynecologyGene signatureMicroarray Analysismedicine.diseaseGene expression profilingmedicine.anatomical_structureReproductive MedicineFemaleTranscriptomeDevelopmental BiologyReproductive BioMedicine Online
researchProduct